Get your full text copy in PDF
Jiajie Yu, Chunjun Zhang, Qingsong Yu, Haibo Yu, Bo Zhang
(Department of General Surgery, Shengzhou People’s Hospital, Branch of First Affiliated Hospital of Zhejiang University, Shengzhou, Zhejiang, China (mainland))
Med Sci Monit 2019; 25:1469-1479
Intrahepatic and distant metastases could be the major cause of treatment failure in hepatocellular carcinoma (HCC). The deep mechanism of HCC metastasis is closely related to the interaction between integrins and extracellular matrix (ECM) in tumor microenvironment.
MATERIAL AND METHODS: In vitro cell adhesion assay was performed to determine the capability of adhering to ECM elements of HCC cells. To modulate the expression status of ADAR1 p110 in tumor cells, lentivirus system was applied. Meanwhile, patients’ HCC samples and orthotopic xenograft mouse model were used for verifying our in vitro data.
RESULTS: ADAR1 p110 could strongly enhance the adhesion of HCC tumor cells to ECM, which was usually regarded as the initiation of tumor invasion. Such phenotype was caused due to up-regulation of ITGA2 both in mRNA and protein level. Moreover, specimen collected from HCC patients revealed a positive correlation between ADAR1 and ITGA2. Finally, ADAR1 p110 promoted HCC metastasis was verified when we applied orthotopic xenograft mouse model.
CONCLUSIONS: ADAR1 could enhance HCC metastasis by promoting tumor cells adhering to ECM via increasing ITGA2 expression. This phenomenon could provide novel information to better understanding the mechanism of HCC metastasis procedure.